Key facts, as of
As of October 8, 2026, Intuitive Surgical (ISRG) trades at $415.41, down 7.3% over the past year. Its 52-week range runs from $328.57 to $603.88; the price is 31.2% below that high. It is 32.6% below its all-time high of $616.00, reached in January 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +404.9%, against +312.9% for the S&P 500 (SPY). It sits 6.5% below its 200-day average of $444.19, the usual sign of a long-term downtrend. Its 30-day volatility is 24.7% annualized, which we rate medium risk. It has a trailing P/E of 47.6.
Cite: Portfolio Terminal, "Intuitive Surgical (ISRG) stock analysis", 2026-10-08. https://portfolio-terminal.com/analyse/isrg
Where it trades today
trading 32% of the way up its 52-week range
How the price has moved
How far it is from its record
Intuitive Surgical (ISRG) is 32.6% below its all-time high of $616.00, reached in January 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +404.9%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- ISRG trades at 47.6x earnings, well above the healthcare average of 22.0x, so the market is already pricing in above-consensus execution.
- ISRG carries a beta of 1.46, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- ISRG is in a bullish short-term regime and only 31.2% below its 52-week high, so the question is whether fundamentals can keep pace with that stronger tape.
Portfolio Use Case
- ISRG is more useful for investors comparing conviction names inside healthcare than for someone looking for a passive “set and forget” holding.
- This name works better as a satellite or higher-conviction growth position because it can amplify market swings in both directions.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in ISRG.
- If the short-term trend rolls over while volume fades, the market may stop paying up for momentum before the fundamentals change.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
Methodology
- Price, market cap, beta, yield, and liquidity fields for ISRG come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as UNH, JNJ, PFE.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for ISRG. Last refresh: Oct 8, 2026, 11:36 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as UNH, JNJ, PFE.
What Intuitive Surgical does
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology;…
Employees
17,021
Industry
Medical Instruments & Supplies
Headquarters
Sunnyvale, United States
What analysts expect
ISRG carries a buy consensus from 30 analysts, with an average price target of $477.47 versus $415.41 today (+14.9%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
ISRG generated $11.03B in trailing revenue (18.5% year over year), with a 28.4% net margin, and $2.62B of free cash flow, supported by $5.22B of net cash.
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
ISRG is in 9 of the 30 ETFs we track. It weighs most in XLV: 2.29% of the fund, holding #11 of 62.
Famous investors who hold it
ISRG is in the latest 13F of 1 of the 15 famous investors we follow. Renaissance Technologies (Founded by Jim Simons) holds the most of it: 0.28% of the portfolio, position #57 of 2,931, as of Q2 2026.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
ISRG beside the healthcare names it is usually measured against.
What the chart is saying
Back above its 50-day average, still under the long-term trend.
recovering- Price is 8.0% above its 50-day average and 6.5% below its 200-day.
- RSI at 63 is neither stretched nor washed out.
- The nearest ceiling is $448.17 (+7.9%), the nearest floor $397.10 (-4.4%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is ISRG a good investment in 2026?
Intuitive Surgical trades at a P/E ratio of 47.6, with medium volatility (24.7% annualized). Recent momentum is positive.
What is the risk level of ISRG?
Based on 30-day volatility of 24.7%, ISRG has MEDIUM risk. Beta of 1.46 indicates higher sensitivity to market movements than average.
Does ISRG pay dividends?
Intuitive Surgical currently does not pay a regular dividend.
How far is ISRG from its all-time high?
Intuitive Surgical is 32.6% below its all-time high of $616.00, reached in January 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +404.9%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold ISRG?
9 of the 30 popular ETFs we track hold Intuitive Surgical. The largest weights: XLV (2.29%), JEPI (0.68%), QQQM (0.59%), QQQ (0.59%) and VUG (0.37%). Measured on each issuer's full holdings file, dated August 31 to October 1, 2026.
How much of VOO is ISRG?
0.20%, as of August 31, 2026: ISRG is holding #89 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $2.02 in Intuitive Surgical.
Which famous investors own ISRG?
Renaissance Technologies (0.28% of Founded by Jim Simons's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for ISRG?
The average analyst price target for Intuitive Surgical (ISRG) is $477.47 based on 30 analyst estimates, about 14.9% above the current price of $415.41. The published range runs from $324.00 to $685.00.
How much revenue does ISRG generate?
Intuitive Surgical reported $11.03B in trailing twelve-month revenue. Revenue growth is running at 18.5% year over year. Net margin sits at 28.4%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare ISRG with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.